Vicarious Surgical Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Vicarious Surgical's earnings have been declining at an average annual rate of -36.9%, while the Medical Equipment industry saw earnings growing at 12.9% annually.
Anahtar bilgiler
-36.9%
Kazanç büyüme oranı
25.8%
EPS büyüme oranı
Medical Equipment Sektör Büyümesi | 8.9% |
Gelir büyüme oranı | n/a |
Özkaynak getirisi | -84.9% |
Net Marj | n/a |
Sonraki Kazanç Güncellemesi | 12 Nov 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Here's Why Vicarious Surgical (NYSE:RBOT) Must Use Its Cash Wisely
Aug 16Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?
Mar 05Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?
Nov 24Vicarious Surgical: Huge Potential But Low Margin Of Safety To Commercialization
Aug 24Here's Why We're Watching Vicarious Surgical's (NYSE:RBOT) Cash Burn Situation
Jul 18Vicarious Surgical: Cash Burn Adds To Downside Risk
May 26Vicarious Surgical Non-GAAP EPS of -$0.16 beats by $0.02
Feb 13Vicarious Surgical Non-GAAP EPS of -$0.18 misses by $0.03
Nov 07Vicarious Surgical Non-GAAP EPS of -$0.16 misses by $0.02
Aug 08Vectoring In On Vicarious Surgical Inc.
Jun 23Vicarious Surgical: Developing Minimally Invasive VR Surgical System
Nov 29Gelir ve Gider Dağılımı
Vicarious Surgical nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 0 | -61 | 28 | 42 |
31 Mar 24 | 0 | -61 | 30 | 43 |
31 Dec 23 | 0 | -71 | 33 | 47 |
30 Sep 23 | 0 | -69 | 35 | 51 |
30 Jun 23 | 0 | -78 | 36 | 50 |
31 Mar 23 | 0 | -64 | 37 | 47 |
31 Dec 22 | 0 | 5 | 36 | 44 |
30 Sep 22 | 0 | 38 | 36 | 41 |
30 Jun 22 | 0 | 18 | 29 | 34 |
31 Mar 22 | 0 | 13 | 23 | 28 |
31 Dec 21 | 0 | -35 | 16 | 22 |
30 Sep 21 | 0 | -61 | 8 | 16 |
30 Jun 21 | 0 | -19 | 6 | 13 |
31 Mar 21 | 0 | -15 | 4 | 11 |
31 Dec 20 | 0 | -13 | 3 | 10 |
Kaliteli Kazançlar: RBOT is currently unprofitable.
Büyüyen Kar Marjı: RBOT is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: RBOT is unprofitable, and losses have increased over the past 5 years at a rate of 36.9% per year.
Büyüme Hızlandırma: Unable to compare RBOT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: RBOT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.7%).
Özkaynak Getirisi
Yüksek ROE: RBOT has a negative Return on Equity (-84.92%), as it is currently unprofitable.